Literature DB >> 32111784

Wedge Resection of Tumor Before Lobectomy for Lung Cancer Could Be a No-touch Isolation Technique.

Motoaki Yasukawa1, Noriyoshi Sawabata2, Takeshi Kawaguchi2, Shigeki Taniguchi2.   

Abstract

BACKGROUND/AIM: Circulating tumor cells (CTCs) can be a surrogate biomarker of prospective prognosis. Surgical manipulation can promote the dissemination of CTCs. Prognosis improvement is expected with the no-touch isolation technique (NTIT), preventing surgical manipulation. The Wedge resection of the tumor site before lobectomy could prevent surgical manipulation during lobectomy for non-small cell lung cancer (NSCLC) and reduce the shedding of tumor cells, similar to a NTIT. This study aimed to evaluate the effect of wedge resection technique. PATIENTS AND METHODS: A total of 624 resected NSCLC patients were retrospectively analyzed. Patients were divided in two groups: Wedge and Non-Wedge. Overall survival (OS) curves were plotted using the Kaplan-Meier method.
RESULTS: The 5-year OS rates were 89.9% and 84.0% in the Wedge and Non-Wedge groups, respectively (p=0.033).
CONCLUSION: The OS in the Wedge group was significantly better than that in the Non-Wedge group. Wedge resection technique for NSCLC may be a NTIT. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Non-small cell lung carcinoma; no-touch isolation technique; prognosis

Mesh:

Substances:

Year:  2020        PMID: 32111784      PMCID: PMC7157838          DOI: 10.21873/invivo.11838

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  29 in total

1.  Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer.

Authors:  Yasutoshi Kuboki; Satoshi Matsusaka; Sayuri Minowa; Harumi Shibata; Mitsukuni Suenaga; Eiji Shinozaki; Nobuyuki Mizunuma; Masashi Ueno; Toshiharu Yamaguchi; Kiyohiko Hatake
Journal:  Anticancer Res       Date:  2013-09       Impact factor: 2.480

Review 2.  Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.

Authors:  Annette Tognela; Kevin J Spring; Therese Becker; Nicole J Caixeiro; Victoria J Bray; Po Yee Yip; Wei Chua; Stephanie H Lim; Paul de Souza
Journal:  Crit Rev Oncol Hematol       Date:  2014-10-12       Impact factor: 6.312

3.  Detection of circulating tumor cells in pulmonary venous blood for resectable non-small cell lung cancer.

Authors:  Chao Lv; Bingtian Zhao; Limin Wang; Panpan Zhang; Yuanyuan Ma; Yuzhao Wang; Nan Wu; Ying Wu; Yue Yang
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

4.  Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.

Authors:  Shiyou Wei; Chenglin Guo; Jintao He; Qunyou Tan; Jiandong Mei; Zhenyu Yang; Chengwu Liu; Qiang Pu; Lin Ma; Yong Yuan; Feng Lin; Yunke Zhu; Hu Liao; Wenping Wang; Zheng Liu; Qiang Li; Bin Jiang; Chuan Li; Liang Xia; Kejia Zhao; Fanyi Gan; Jiahan Cheng; Zhu Wu; Yun Wang; Yidan Lin; Yingli Kou; Guowei Che; Longqi Chen; Jing Li; Lunxu Liu
Journal:  JAMA Surg       Date:  2019-07-17       Impact factor: 14.766

5.  Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.

Authors:  Marc Oliver Bodendorf; Victor Haas; Hans-Gerd Laberke; Gunnar Blumenstock; Peter Wex; Thomas Graeter
Journal:  Lung Cancer       Date:  2008-09-14       Impact factor: 5.705

6.  Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer.

Authors:  Hideyasu Tsumura; Takefumi Satoh; Hiromichi Ishiyama; Ken-Ichi Tabata; Kouji Takenaka; Akane Sekiguchi; Masaki Nakamura; Masashi Kitano; Kazushige Hayakawa; Masatsugu Iwamura
Journal:  Int J Mol Sci       Date:  2017-01-11       Impact factor: 5.923

7.  Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study.

Authors:  Xinchun Duan; Yujie Zhu; Yong Cui; Zhenrong Yang; Shijie Zhou; Yi Han; Daping Yu; Ning Xiao; Xiaoqing Cao; Yunsong Li; Shuku Liu; Zitong Wang; Wen Zhang; Lin Feng; Kaitai Zhang; Jianzhong Shou; Zhidong Liu; Shaofa Xu
Journal:  Thorac Cancer       Date:  2018-12-04       Impact factor: 3.500

8.  Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.

Authors:  Yang Li; Xudong Tian; Lei Gao; Xiaohong Jiang; Rao Fu; Tingting Zhang; Tianying Ren; Ping Hu; Yaping Wu; Peige Zhao; Dawei Yang
Journal:  Cancer Med       Date:  2019-05-27       Impact factor: 4.452

Review 9.  CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs).

Authors:  Tala Tayoun; Vincent Faugeroux; Marianne Oulhen; Agathe Aberlenc; Patrycja Pawlikowska; Françoise Farace
Journal:  Cells       Date:  2019-09-25       Impact factor: 6.600

10.  Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer.

Authors:  Tamara M H Gall; Jimmy Jacob; Adam E Frampton; Jonathan Krell; Charis Kyriakides; Leandro Castellano; Justin Stebbing; Long R Jiao
Journal:  JAMA Surg       Date:  2014-05       Impact factor: 14.766

View more
  3 in total

1.  Vein-first Lobectomy for Lung Cancer Assessed According to the Status of Clustered Circulating Tumour Cells.

Authors:  Noriyoshi Sawabata; Shigeru Nakane; Daiki Yoshikawa; Takashi Watanabe; Takeshi Kawaguchi; Noriko Ouji-Sageshima; Keiji Kushibe; Toshihiro Ito
Journal:  Cancer Diagn Progn       Date:  2021-11-03

2.  Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma.

Authors:  Lu Liang; Yueying Liu; Shiyao Jiang; Jingjing Huang; Hua He; Li Shen; Li Cong; Yiqun Jiang
Journal:  J Immunol Res       Date:  2022-05-29       Impact factor: 4.493

3.  Wedge resection before lobectomy for patients with T1N0M0 non-small cell lung cancer: a propensity score matching analysis.

Authors:  Yuan Zeng; Ying Huang; Junhui Fu; Ke Xu; Wenhua Liang; Fei Cui; Zhexue Hao; Xukai Li; Tuo Xing; Jianxing He; Jun Liu
Journal:  Ann Transl Med       Date:  2022-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.